These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 28467708

  • 1. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
    Watanabe H, Ono M, Ariyoshi T, Katayanagi R, Saji H.
    ACS Chem Neurosci; 2017 Aug 16; 8(8):1656-1662. PubMed ID: 28467708
    [Abstract] [Full Text] [Related]

  • 2. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, Villemagne VL.
    Eur J Pharmacol; 2009 Sep 01; 617(1-3):54-8. PubMed ID: 19576880
    [Abstract] [Full Text] [Related]

  • 3. Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.
    Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R.
    Neurochem Res; 2006 Sep 01; 31(9):1153-62. PubMed ID: 16947080
    [Abstract] [Full Text] [Related]

  • 4. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K.
    Neurosci Lett; 1999 May 14; 266(3):213-6. PubMed ID: 10465711
    [Abstract] [Full Text] [Related]

  • 5. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
    Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG.
    Brain Pathol; 2014 Jan 14; 24(1):25-32. PubMed ID: 23714377
    [Abstract] [Full Text] [Related]

  • 6. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jäkälä P, Hartmann T, Beyreuther K, Masters CL, Li QX.
    Am J Pathol; 1999 Oct 14; 155(4):1173-81. PubMed ID: 10514400
    [Abstract] [Full Text] [Related]

  • 7. Design and Development of Benzothiazole-Based Fluorescent Probes for Selective Detection of Aβ Aggregates in Alzheimer's Disease.
    Mallesh R, Khan J, Pradhan K, Roy R, Jana NR, Jaisankar P, Ghosh S.
    ACS Chem Neurosci; 2022 Aug 17; 13(16):2503-2516. PubMed ID: 35926183
    [Abstract] [Full Text] [Related]

  • 8. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M, Gelpi E, Martí MJ, Compta Y.
    Neuropathol Appl Neurobiol; 2016 Aug 17; 42(5):451-62. PubMed ID: 26810462
    [Abstract] [Full Text] [Related]

  • 9. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I, Iashchishyn IA, Moskalenko RA, Wang C, Wärmländer SKTS, Wallin C, Gräslund A, Kovacs GG, Morozova-Roche LA.
    J Neuroinflammation; 2018 Jun 04; 15(1):172. PubMed ID: 29866153
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of amyloid-β plaque formation by α-synuclein.
    Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Müller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M.
    Nat Med; 2015 Jul 04; 21(7):802-7. PubMed ID: 26099047
    [Abstract] [Full Text] [Related]

  • 11. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 12. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U, Kayed R.
    Prog Neurobiol; 2022 Jul 14; 214():102270. PubMed ID: 35447272
    [Abstract] [Full Text] [Related]

  • 13. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC.
    Neurobiol Aging; 2005 Jul 14; 26(8):1183-92. PubMed ID: 15917102
    [Abstract] [Full Text] [Related]

  • 14. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y, Miller Y.
    ACS Chem Neurosci; 2016 Jan 20; 7(1):46-55. PubMed ID: 26479553
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging α-synuclein aggregates.
    Watanabe H, Ariyoshi T, Ozaki A, Ihara M, Ono M, Saji H.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6398-6403. PubMed ID: 29111367
    [Abstract] [Full Text] [Related]

  • 16. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
    Jia J, Cui M, Dai J, Liu B.
    Mol Pharm; 2015 Aug 03; 12(8):2937-46. PubMed ID: 26065726
    [Abstract] [Full Text] [Related]

  • 17. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C, Yahi N, Flores A, Boutemeur S, Kourdougli N, Chahinian H, Fantini J.
    Biochim Biophys Acta; 2016 Feb 03; 1862(2):213-22. PubMed ID: 26655601
    [Abstract] [Full Text] [Related]

  • 18. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN, Majbour NK, Paleologou KE, Ardah MT, van Dam E, van de Berg WD, Forrest SL, Parkkinen L, Gai WP, Hattori N, Takanashi M, Lee SJ, Mann DM, Imai Y, Halliday GM, Li JY, El-Agnaf OM.
    Neurobiol Dis; 2015 Jul 03; 79():81-99. PubMed ID: 25937088
    [Abstract] [Full Text] [Related]

  • 19. Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein.
    Araki K, Yagi N, Aoyama K, Choong CJ, Hayakawa H, Fujimura H, Nagai Y, Goto Y, Mochizuki H.
    Proc Natl Acad Sci U S A; 2019 Sep 03; 116(36):17963-17969. PubMed ID: 31427526
    [Abstract] [Full Text] [Related]

  • 20. Push-pull benzothiazole derivatives as probes for detecting beta-amyloid plaques in Alzheimer's brains.
    Ono M, Hayashi S, Kimura H, Kawashima H, Nakayama M, Saji H.
    Bioorg Med Chem; 2009 Oct 01; 17(19):7002-7. PubMed ID: 19740669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.